A digital support program for adolescents at risk of suicide
A Digital Psychoeducational Social Network Intervention for Suicidal Adolescents
This study is testing a new online support program called eYST for teens who have been in the hospital because of suicidal thoughts or attempts, helping them connect with caring adults for encouragement and support as they work on their recovery.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oui Therapeutics, INC NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10705306 on NIH RePORTER |
What this research studies
This research focuses on developing a digital version of a support program for adolescents who have been hospitalized due to suicidal thoughts or attempts. The program, called eYST, aims to connect these adolescents with selected adults who will provide support and encouragement for treatment adherence and positive behavior changes. By digitizing the training for both the adolescents and their support adults, the program seeks to make suicide prevention more accessible and scalable. The approach includes automating administrative tasks to reduce the burden on mental health professionals involved in the intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 21 who have been hospitalized for suicidal thoughts or attempts.
Not a fit: Patients who are not hospitalized for suicidal ideation or attempts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of future suicide attempts among adolescents by providing them with a structured support network.
How similar studies have performed: Previous research has shown that similar psychoeducational interventions can effectively reduce suicide risk among adolescents, indicating a promising approach.
Where this research is happening
New Haven, United States
- Oui Therapeutics, INC — New Haven, United States (Active)
Researchers
- Principal investigator: Simon, Patricia — Oui Therapeutics, INC
- Study coordinator: Simon, Patricia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.